Servier, an international pharmaceutical group, and Google Cloud announce a strategic collaboration that marks a new stage in the digital transformation initiated by Servier. This agreement, centered on the use of data and artificial intelligence (AI), aims in particular to increase the Group’s therapeutic innovation capacities for the benefit of patients and in compliance with the applicable regulatory framework.
For Virginie Dominguez, Executive Vice-President Digital, Data and Information Systems of the Servier group: “Scientific innovation combined with technological power will make it possible to make significant progress in the overall care of patients. Indeed, data and artificial intelligence open up tremendous prospects, both for the discovery of new drugs, and in the prevention of diseases or the improvement of treatment compliance, all along the supply chain. value of a pharmaceutical laboratory. We were looking for a high-level partner to support us on these technologies. We chose Google Cloud for its knowledge of the healthcare industry, its power to innovate, and its commitment to GDPR-compliant cloud services and digital sovereignty requirements. »
As part of this partnership, Google Cloud is supporting Servier in its migration to the cloud, and will provide a set of innovative tools to provide increased computing power and accelerate data analysis and understanding. thanks to artificial intelligence.
For Anthony Cirot, Managing Director of Google Cloud France: “Our extensive and ambitious collaboration with Servier perfectly illustrates our approach to cloud technologies: how to support innovation and ultimately the growth of French companies, with relevant skills and solutions, a adapted support and a commitment alongside the teams, all under the highest standards of compliance, security and confidentiality. »
Google Cloud technologies will benefit all areas of the business, from production to research to distribution. In the field of R&D, for example, Google’s cloud solutions will facilitate the work of Servier researchers who use increasingly sophisticated algorithms to accelerate the discovery and availability of new therapeutic solutions. These algorithms, trained on large amounts of anonymized data, generate models facilitating the identification of molecules of interest and therapeutic targets for a better probability of success during the clinical phases. Google Cloud technologies will also help Servier optimize its drug production and distribution chain, thus strengthening the continuity of supply of treatments to avoid stock-outs which constitute a public health problem of concern to patients and healthcare professionals.
By collaborating with Google Cloud, and its ecosystem of partners, Servier projects itself into the co-construction of innovative initiatives, such as the acceleration of the development of new drugs thanks to artificial intelligence, or even advanced data analysis. in real life to provide new scientific evidence of the efficacy and tolerance of treatments.
In order to strengthen the skills of the teams in the field of digital technologies, Servier has also developed advanced acculturation and training programs for all of its employees worldwide. Google Cloud, associated with this program, will deliver training on data and AI technologies, thus promoting the transition of teams towards a Data Driven culture.
 The General Data Protection Regulation